C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/4353 (2006.01) A61P 19/02 (2006.01) A61P 19/08 (2006.01) C07D 471/10 (2006.01) C07D 471/14 (2006.01) C07D 491/04 (2006.01) C07D 491/147 (2006.01)
Patent
CA 2689945
The present invention relates to compounds of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases, including cathepsins B, K, C, F, H, L, O, S, W and X. Of particular interest are diseases associated with Cathepsin K.
L'invention concerne des composés de la formule (I) et des compositions destinés au traitement de maladies associées à l'activité cystéine protéase. Les composés de l'invention sont des inhibiteurs réversibles des cystéine protéases, entre autres des cathepsines B, K, C, F, H, L, O, S, W et X. L'invention offre un intérêt particulier dans le traitement de maladies associées à la cathepsine K.
Dossetter Alexander Graham
Heron Nicola Murdoch
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
1-cyanocyclopropyl-derivatives as cathepsin k inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1378871